Related Experiment Video
Updated: Nov 29, 2025

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation
Published on: January 10, 2025
Kidney Ischemia-Reperfusion Decreases Hydrogen Sulfide and Increases Oxidative Stress in the Heart
Charith U B Wijerathne1,2, Susara Madduma Hewage1,3, Yaw L Siow1,3,4
1St. Boniface Hospital Research Centre, Winnipeg, MB R2H 2A6, Canada.
Insights
Acute kidney injury (AKI) impairs heart health by reducing protective hydrogen sulfide (H2S) production and increasing oxidative stress. This study reveals AKI disrupts the CSE enzyme, leading to cardiac damage and higher cardiovascular disease risk.
Area of Science:
- Cardiovascular Science
- Nephrology
- Biochemistry
Background:
- Acute kidney injury (AKI) is linked to increased cardiovascular disease risk.
- The mechanisms of AKI-induced heart injury remain unclear.
- Hydrogen sulfide (H2S) at physiological levels offers cardiovascular protection via redox balance and vasodilation.
- Cystathionine gamma-lyase (CSE) is crucial for cardiac H2S generation.
Purpose of the Study:
- To investigate the impact of AKI on cardiac H2S production.
- To assess oxidative stress markers in the heart following AKI.
- To explore the role of CSE and Nrf2 pathways in AKI-related cardiac dysfunction.
Main Methods:
- AKI was induced using kidney ischemia-reperfusion in Sprague-Dawley rats.
- Plasma creatinine and blood urea nitrogen were measured to confirm AKI.
- Cardiac and plasma oxidative stress markers (lipid peroxidation, glutathione) were analyzed.
- CSE expression, H2S levels, nuclear Nrf2, and inflammatory cytokines (IL-6, TNF-α) were quantified in heart tissue.
Main Results:
- AKI induction led to elevated plasma creatinine and blood urea nitrogen.
- Significant increases in lipid peroxidation and decreases in glutathione were observed systemically and cardially.
- Kidney ischemia-reperfusion resulted in reduced cardiac CSE expression and H2S production.
- Nuclear Nrf2 levels decreased, while cardiac IL-6 and TNF-α expression increased post-AKI.
Conclusions:
- AKI significantly down-regulates CSE-mediated H2S production in the heart.
- AKI exacerbates cardiac oxidative stress and inflammation.
- Reduced H2S and increased oxidative stress in the heart following AKI may contribute to cardiovascular complications.
Abstract:
Patients with acute kidney injury (AKI) have an increased risk of cardiovascular disease. The underlying mechanism of AKI-induced heart injury is not well-understood. Hydrogen sulfide (H2S), at physiological concentrations, has been implicated in cardiovascular protection through redox balance and vessel relaxation. Cystathionine gamma-lyase (CSE) plays an essential role in H2S production in the heart. The present study investigated the effect of AKI on H2S production and oxidative stress in the heart. AKI was induced by kidney ischemia-reperfusion in male and female Sprague-Dawley rats, which led to an increase in plasma creatinine and blood urea nitrogen levels. There was a significant increase in lipid peroxidation and a decrease in glutathione (antioxidant) levels in the plasma and heart, indicating systemic and cardiac oxidative stress. Kidney ischemia-reperfusion reduced CSE expression and H2S production in the heart. There was a decrease in antioxidant transcription factor Nrf2 level in the nucleus and an increase in inflammatory cytokine (IL-6, TNF-α) expression in the heart. These results suggest that AKI can down-regulate CSE-mediated H2S production, reduce glutathione levels and increase oxidative stress in the heart. This may contribute to an increased risk of cardiovascular disease in AKI.
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Heart Failure Drugs: Diuretics

